Mapping contrast agent uptake and retention in MRI studies of myocardial perfusion: Case control study of dogs with Duchenne muscular dystrophy

International Journal of Cardiovascular Imaging

Volumn 29, Issue 4, 2013, Pages 819-826

  Kerwin, William S ^a   Naumova, Anna ^a   Storb, Rainer ^b,c   Tapscott, Stephen J ^b,c   Wang, Zejing ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Contrast agents; Duchenne muscular dystrophy; Kinetic models; MRI; Myocardial perfusion

Indexed keywords

CONTRAST MEDIUM; CREATINE KINASE; GADOLINIUM PENTETATE;

ARTICLE; BREATHING DISORDER; CARDIOVASCULAR MAGNETIC RESONANCE; CINEANGIOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOG; DUCHENNE MUSCULAR DYSTROPHY; EATING DISORDER; GENOTYPE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE PERFUSION; HEART RATE; HEART STROKE VOLUME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOISOTOPE DECAY; SYMPTOMATOLOGY; WALKING DIFFICULTY; ANIMAL; BIOLOGICAL MODEL; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC USE; DISEASE MODEL; HEART MUSCLE; METABOLISM; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIAL PERFUSION IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; TISSUE DISTRIBUTION;

ANIMALS; CONTRAST MEDIA; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; DOGS; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING, CINE; MODELS, BIOLOGICAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; TISSUE DISTRIBUTION;

EID: 84877924878     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-012-0137-y     Document Type: Article

References (31)

1. Cury RC, Cattani CA, Gabure LA, Racy DJ, de Gois JM, Siebert U, Lima SS, Brady TJ (2006) Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology 240:39-45
2. Bingham SE, Hachamovitch R (2011) Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress perfusion, delayed enhancement, and left ventricular function over preimaging information for the prediction of adverse events. Circulation 123:1509-1518
3. Korosoglou G, Elhmidi Y, Steen H, Schellberg D, Riedle N, Ahrens J, Lehrke S, Merten C, Lossnitzer D, Radeleff J, Zugck C, Giannitsis E, Katus HA (2010) Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol 56:1225-1234
4. Doesch C, Seeger A, Doering J, Herdeg C, Burgstahler C, Claussen CD, Gawaz M, Miller S, May AE (2009) Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc Imaging 2:424-433
5. Tsukiji M, Nguyen P, Narayan G, Hellinger J, Chan F, Herfkens R, Pauly JM, McConnell MV, Yang PC (2006) Peri-infarct ischemia determined by cardiovascular magnetic resonance evaluation of myocardial viability and stress perfusion predicts future cardiovascular events in patients with severe ischemic cardiomyopathy. J Cardiovasc Magn Reson 8:773-779
6. Selvanayagam JB, Jerosch-Herold M, Porto I, Sheridan D, Cheng AS, Petersen SE, Searle N, Channon KM, Banning AP, Neubauer S (2005) Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation 112:3289-3296
7. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, Kraitchman DL (2008) Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art (review). J Cardiovasc Magn Reson 10:18
8. Jerosch-Herold M (2010) Quantification of myocardial perfusion by cardiovascular magnetic resonance (review). J Cardiovasc Magn Reson 12:57
9. Tyler KL (2003) Origins and early descriptions of "Duchenne muscular dystrophy". Muscle Nerve 28:402-422
10. Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes (review). Lancet Neurol 2:731-740
11. Finsterer J, Stollberger C (2003) The heart in human dystrophinopathies (review). Cardiology 99:1-19
12. Duan D (2006) Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. Hum Mol Genet 15(Spec. No. 2):R253-R261
13. Hoogerwaard EM, van der Wouw PA, Wilde AA, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, van Essen AJ, Leschot NJ, de Visser M (1999) Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 9:347-351
14. Silva MC, Meira ZM, Gurgel GJ, da Silva MM, Campos AF, Barbosa MM, Starling Filho GM, Ferreira RA, Zatz M, Rochitte CE (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49:1874-1879
15. Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E, Gottliebson WM (2009) Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovasc Imaging 25:57-63
16. Bilchick KC, Salerno M, Plitt D, Dori Y, Crawford TO, Drachman D, Thompson WR (2011) Prevalence and distribution of regional scar in dysfunctional myocardial segments in Duchenne muscular dystrophy. J Cardiovasc Magn Reson 13:20
17. Perloff JK, Henze E, Schelbert HR (1984) Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. Circulation 69:33-42
18. Nishimura T, Yanagisawa A, Sakata H, Sakata K, Shimoyama K, Ishihara T, Yoshino H, Ishikawa K (2001) Thallium-201 single photon emission computed tomography (SPECT) in patients with Duchenne's progressive muscular dystrophy: a histopathologic correlation study. Jpn Circ J 65:99-105
19. Kelle S, Graf K, Dreysse S, Schnackenburg B, Fleck E, Klein C (2010) Evaluation of contrast wash-in and peak enhancement in adenosine first pass perfusion CMR in patients post bypass surgery. J Cardiovasc Magn Reson 12:28
20. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E (2003) Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108:432-437
21. Diesbourg LD, Prato FS, Wisenberg G, Drost DJ, Marshall TP, Carroll SE, O'Neill B (1992) Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 23:239-253
22. Pack NA, Dibella EV, Wilson BD, McGann CJ (2008) Quantitative myocardial distribution volume from dynamic contrast-enhanced MRI. Magn Reson Imaging 26:532-542
23. Li X, Springer CS Jr, Jerosch-Herold M (2009) First-pass dynamic contrast-enhanced MRI with extravasating contrast reagent: evidence for human myocardial capillary recruitment in adenosine-induced hyperemia. NMR Biomed 22:148-157
24. Patel PP, Koppenhafer SL, Scholz TD (1995) Measurement of kinetic perfusion parameters of gadoteridol in intact myocardium: effects of ischemia/reperfusion and coronary vasodilation. Magn Reson Imaging 13:799-806
25. Valentine BA, Cooper BJ, de Lahunta A, O'Quinn R, Blue JT (1988) Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J Neurol Sci 88:69-81
26. Kerwin WS, Cai J, Yuan C (2002) Noise and motion correction in dynamic contrast-enhanced MRI for analysis of atherosclerotic lesions. Magn Reson Med 47:1211-1217
27. Kerwin WS, Oikawa M, Yuan C, Jarvik GP, Hatsukami TS (2008) MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med 59:507-514
28. Ahmad N, Welch I, Grange R, Hadway J, Dhanvantari S, Hill D, Lee TY, Hoffman LM (2011) Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice. BMC Muscul Disord 12:127
29. Melacini P, Vianello A, Villanova C, Fanin M, Miorin M, Angelini C, Dalla VS (1996) Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscul Disord 6:367-376
30. Lanza GA, Dello RA, Giglio V, De Luca L, Messano L, Santini C, Ricci E, Damiani A, Fumagalli G, De Martino G, Mangiola F, Bellocci F (2001) Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function. Am Heart J 141:808-812
31. van Bockel EA, Lind JS, Zijlstra JG, Wijkstra PJ, Meijer PM, van den Berg MP, Slart RH, Aarts LP, Tulleken JE (2009) Cardiac assessment of patients with late stage Duchenne muscular dystrophy. Netherlands Heart J 17:232-237